Smoking Cessation Training: Macao’s Department of Health ran a two-day Comprehensive Smoking Cessation Intervention workshop for 130+ healthcare professionals from Hong Kong, the Mainland and Macao, covering counselling, relapse prevention, tobacco dependence treatment, motivational interviewing and pharmacotherapy, with added focus on helping construction-site workers quit after the comprehensive smoking ban took effect. Cancer Drug Deal: GSK agreed to pay Hutchmed $110 million upfront for HMPL-A830, a KRAS-EGFR antibody-targeted therapy conjugate aimed first at colorectal, pancreatic and lung cancers; Hutchmed keeps control in Mainland China, Hong Kong, Macau and Taiwan while GSK takes over development and commercialization elsewhere. Heart Medication Approval: Milestone Pharmaceuticals said China’s NMPA approved etripamil nasal spray for adults with paroxysmal supraventricular tachycardia (PSVT), with Everest Medicines leading commercialization in Greater China (including Macau). Medical Logistics Pilot: Macao is trialling drone delivery of medical samples between Conde de São Januário Hospital and Peking Union Medical College Hospital’s Macao Medical Center, targeting 10–15 minute trips despite dense airspace restrictions. Wellness Wearable Launch: Macau Ke Hon Technology launched KEHON RING, a screenless “wellness” wearable positioned for B2B wholesale and corporate gifting, featuring a lifetime zero-subscription model. Public Health Safety: A fatal construction-site accident led to a $640,000 fine for In Construction Limited over safety legislation violations.